CD4 and neoplasm: The peripheral blood constitutes the most important source of Tregs and the percentage of Tregs probably depends directly on the presence of a tumor, because Treg frequency correlate with the number and activity of CD4+ effector T cells involved in the antitumor response (activation via the TCR receptor) [43] and the stimulating activity of tumor antigens [34–37].